title: Disruption of epithelial barrier integrity by Salmonella enterica serovar typhimurium requires geranylgeranylated proteins.
abstract: Epithelial cells that line the human intestinal mucosa constitute the initial sites of host invasion by bacterial pathogens. A number of bacteria, such as Salmonella and Yersinia spp., have been shown to disrupt the integrity of the epithelial barrier, although little is known about the mechanisms underlying that effect. We found that polarized MDCK-1 epithelial cells infected with invasive Salmonella enterica serovar Typhimurium SL1344 exhibited marked changes in F-actin organization, an increase in the paracellular flux of dextran, and a rapid decrease in transepithelial electrical resistance (TER). In contrast, infection with an isogenic noninvasive mutant (hilA) increased the TER in these cells. Pretreating MDCK-1 cells with the inhibitors for tyrosine kinase (genistein) or phosphatidylinositol 3-kinase (wortmannin) did not affect invasion and subsequent perturbation of the epithelial barrier by serovar Typhimurium. Instead, the geranylgeranyltransferase 1 inhibitor GGTI-298, but not the farnesyltransferase inhibitor FTI-277, clearly reversed the capacity of serovar Typhimurium to disrupt the epithelial barrier. The substrates for GGTI-298 include Rho family GTPases, as indicated by inhibiting prenylation of Rac1 and Cdc42. Infection with wild-type serovar Typhimurium increased the level of activated Rac1 and Cdc42 and caused these proteins to accumulate apically in MDCK-1 cells. This Salmonella-induced accumulation of Rac1 and Cdc42 and alteration of the junction-associated proteins ZO-1, occludin, and E-cadherin in MDCK-1 cells were markedly inhibited by GGTI-298. These results suggest that activation of geranylgeranylated proteins, including Rac1 and Cdc42, is critical for disruption of barrier integrity by serovar Typhimurium in polarized MDCK-1 cells.
authors.affiliation: Division of Medical Microbiology, Department of Molecular and Clinical Medicine, Linköping University, Sweden. farta@imk.liu.se
authors.forename: Farideh
authors.initials: F
authors.lastname: Tafazoli
authors.forename: Karl-Eric
authors.initials: KE
authors.lastname: Magnusson
authors.forename: Limin
authors.initials: L
authors.lastname: Zheng
mesh_terms: D000199:Actins / Q000378:metabolism*; D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D002460:Cell Line; D004224:Diterpenes; D004847:Epithelial Cells / Q000382:microbiology*; D008855:Microscopy, Electron, Scanning; D011106:Polyisoprenyl Phosphates / Q000378:metabolism*; D017368:Protein Prenylation; D011506:Proteins / Q000378:metabolism*; D012486:Salmonella typhimurium / Q000187:drug effects / Q000472:pathogenicity*; D020764:cdc42 GTP-Binding Protein / Q000378:metabolism; D020744:rac GTP-Binding Proteins / Q000378:metabolism
chemical_list: D000199:Actins; D001549:Benzamides; D004224:Diterpenes; C102521:GGTI 298; D011106:Polyisoprenyl Phosphates; D011506:Proteins; D019883:Alkyl and Aryl Transferases; C083291:geranylgeranyltransferase type-I; D020764:cdc42 GTP-Binding Protein; D020744:rac GTP-Binding Proteins; C002963:geranylgeranyl pyrophosphate